Article

Aimee Tharaldson, PharmD, Talks About Specialty Drug Approvals

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics at Express Scripts, Inc, says that the increasing of specialty medication approvals impacts both patients and payers.

In this video, Aimee Tharaldson, PharmD, Senior Clinical Consultant, Emerging Therapeutics at Express Scripts, says that the increasing of specialty medication approvals impacts both patients and payers.

With the increased approvals, patients are now finding themselves with more medication options. Payers, however, are concerned with the increase due to the cost of the specialty drugs.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Hans Lee
Dr María Díez Campelo
Nicole Bajic, MD
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Dr Carrie Kitko
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo